Paul J Meis

Summary

Affiliation: Wake Forest University School of Medicine
Country: USA

Publications

  1. ncbi request reprint The role of 17 alpha-hydroxyprogesterone caproate in the prevention of preterm birth
    Paul J Meis
    Department of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Wake Forest University Health Sciences, Medical Center Blvd, Winston Salem, NC 27157, USA
    Womens Health (Lond Engl) 2:819-24. 2006
  2. ncbi request reprint The preterm prediction study: elevated cervical ferritin levels at 22 to 24 weeks of gestation are associated with spontaneous preterm delivery in asymptomatic women
    Patrick S Ramsey
    National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network, USA
    Am J Obstet Gynecol 186:458-63. 2002
  3. ncbi request reprint Progesterone treatment to prevent preterm birth
    Paul J Meis
    Section of Maternal Fetal Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Clin Obstet Gynecol 47:784-95; discussion 881-2. 2004
  4. ncbi request reprint Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
    Paul J Meis
    Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, NC 27157, USA
    N Engl J Med 348:2379-85. 2003
  5. ncbi request reprint Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Paul J Meis
    National Institute of Child Health and Human Development, Rockville, Maryland, USA
    Obstet Gynecol 106:557-61. 2005
  6. ncbi request reprint Progesterone treatment to prevent preterm birth
    Paul J Meis
    Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Drugs 64:2463-74. 2004
  7. ncbi request reprint 17 hydroxyprogesterone for the prevention of preterm delivery
    Paul J Meis
    Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Winston Salem, North Carolina, USA
    Obstet Gynecol 105:1128-35. 2005
  8. pmc Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment
    Cynthia Gyamfi-Bannerman
    Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA
    Obstet Gynecol 120:1332-7. 2012
  9. ncbi request reprint Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery
    Catherine Y Spong
    National Institute of Child Health and Human Development, Bethesda, MD, USA
    Am J Obstet Gynecol 193:1127-31. 2005
  10. pmc Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo
    Mark A Klebanoff
    National Institute of Child Health and Human Development, Bethesda, MD, USA
    Am J Obstet Gynecol 199:506.e1-7. 2008

Detail Information

Publications23

  1. ncbi request reprint The role of 17 alpha-hydroxyprogesterone caproate in the prevention of preterm birth
    Paul J Meis
    Department of Obstetrics and Gynecology, Section of Maternal Fetal Medicine, Wake Forest University Health Sciences, Medical Center Blvd, Winston Salem, NC 27157, USA
    Womens Health (Lond Engl) 2:819-24. 2006
    ..Although this drug is not currently commercially available, an application has been made to the US FDA to produce 17 alpha-hydroxyprogesterone caproate, as Gestiva() for the prevention of preterm delivery...
  2. ncbi request reprint The preterm prediction study: elevated cervical ferritin levels at 22 to 24 weeks of gestation are associated with spontaneous preterm delivery in asymptomatic women
    Patrick S Ramsey
    National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network, USA
    Am J Obstet Gynecol 186:458-63. 2002
    ..Our objective was to determine whether elevated levels of ferritin in the genital tract may be a potent marker to identify patients at risk for spontaneous preterm delivery...
  3. ncbi request reprint Progesterone treatment to prevent preterm birth
    Paul J Meis
    Section of Maternal Fetal Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Clin Obstet Gynecol 47:784-95; discussion 881-2. 2004
  4. ncbi request reprint Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
    Paul J Meis
    Department of Obstetrics and Gynecology, Wake Forest University, Winston Salem, NC 27157, USA
    N Engl J Med 348:2379-85. 2003
    ..The results of several small trials have suggested that 17 alpha-hydroxyprogesterone caproate (17P) may reduce the risk of preterm delivery...
  5. ncbi request reprint Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Paul J Meis
    National Institute of Child Health and Human Development, Rockville, Maryland, USA
    Obstet Gynecol 106:557-61. 2005
    ..To examine how demographic and pregnancy characteristics can affect the risk of recurrent preterm delivery and the how the effectiveness of progesterone treatment for prevention alters these relationships...
  6. ncbi request reprint Progesterone treatment to prevent preterm birth
    Paul J Meis
    Department of Obstetrics and Gynecology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
    Drugs 64:2463-74. 2004
    ..Trials of progestogens after the occurrence of symptoms of labour have shown them to be ineffective in prolonging pregnancy...
  7. ncbi request reprint 17 hydroxyprogesterone for the prevention of preterm delivery
    Paul J Meis
    Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Winston Salem, North Carolina, USA
    Obstet Gynecol 105:1128-35. 2005
    ..Four trials reporting the use of a progestational drug in patients with symptoms of preterm labor found no efficacy in prolonging pregnancy, and the use of 17P or other progestational drugs as tocolytic therapy should not be encouraged...
  8. pmc Risk of uterine rupture and placenta accreta with prior uterine surgery outside of the lower segment
    Cynthia Gyamfi-Bannerman
    Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA
    Obstet Gynecol 120:1332-7. 2012
    ..Although theoretically at increased risk for placenta accreta, this risk has not been well-quantified. Our objective was to estimate and compare the risks of uterine rupture and placenta accreta in women with prior uterine surgery...
  9. ncbi request reprint Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery
    Catherine Y Spong
    National Institute of Child Health and Human Development, Bethesda, MD, USA
    Am J Obstet Gynecol 193:1127-31. 2005
    ..We hypothesized that treatment with 17-OHP caproate is more effective in prolonging pregnancy depending on the gestational age of the earliest previous preterm birth (20-27.9, 28-33.9 vs 34-36.9 weeks)...
  10. pmc Salivary progesterone and estriol among pregnant women treated with 17-alpha-hydroxyprogesterone caproate or placebo
    Mark A Klebanoff
    National Institute of Child Health and Human Development, Bethesda, MD, USA
    Am J Obstet Gynecol 199:506.e1-7. 2008
    ....
  11. ncbi request reprint Midpregnancy genitourinary tract infection with Chlamydia trachomatis: association with subsequent preterm delivery in women with bacterial vaginosis and Trichomonas vaginalis
    William W Andrews
    Department of Obstetrics and Gynecology, University of Alabama, Birmingham, AL, USA
    Am J Obstet Gynecol 194:493-500. 2006
    ..The objective of the study was to estimate whether midpregnancy genitourinary tract infection with Chlamydia trachomatis is associated with an increased risk of subsequent preterm delivery...
  12. ncbi request reprint Plasma CRH measurement at 16 to 20 weeks' gestation does not predict preterm delivery in women at high-risk for preterm delivery
    Baha Sibai
    Department of Obstetrics and Gynecology, University of Cincinnati School of Medicine, Cincinnati, OH 45267, USA
    Am J Obstet Gynecol 193:1181-6. 2005
    ..The purpose of this study was to examine the utility of a single second-trimester plasma corticotropin-releasing hormone measurement as a marker for preterm delivery in women at high risk for preterm delivery...
  13. pmc Effect of antenatal corticosteroids on respiratory morbidity in singletons after late-preterm birth
    Cynthia Gyamfi-Bannerman
    Department of Obstetrics and Gynecology, Columbia University, New York, New York 10032, USA
    Obstet Gynecol 119:555-9. 2012
    ..To evaluate whether neonates born to women who previously had received antenatal corticosteroids and then delivered a late-preterm-birth neonate had less respiratory morbidity compared with those not exposed to antenatal corticosteroids...
  14. pmc Timing of elective repeat cesarean delivery at term and neonatal outcomes
    Alan T N Tita
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, 619 19th St South, Birmingham, AL 35249, USA
    N Engl J Med 360:111-20. 2009
    ..We assessed associations between elective cesarean delivery at term (37 weeks of gestation or longer) but before 39 weeks of gestation and neonatal outcomes...
  15. pmc Timing of elective repeat cesarean delivery at term and maternal perioperative outcomes
    Alan T N Tita
    Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA
    Obstet Gynecol 117:280-6. 2011
    ..We assessed whether delivery before 39 weeks is justifiable on the basis of decreased adverse maternal outcomes...
  16. pmc The effect of 17-alpha hydroxyprogesterone caproate on the risk of gestational diabetes in singleton or twin pregnancies
    Cynthia Gyamfi
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Am J Obstet Gynecol 201:392.e1-5. 2009
    ..To compare the rates of gestational diabetes among women who received serial doses of 17-alpha hydroxyprogesterone caproate vs placebo...
  17. ncbi request reprint Perinatal outcomes in women with preterm rupture of membranes between 24 and 32 weeks of gestation and a history of vaginal bleeding
    Michael D Hnat
    Department of Obstetrics and Gynecology, UT Southwestern Medical Center, Dallas, TX 75390 9032, USA
    Am J Obstet Gynecol 193:164-8. 2005
    ..The purpose of this study was to compare perinatal outcomes among women with conservatively treated preterm premature rupture of membranes at 24 to 32 weeks of gestation in the presence or absence of vaginal bleeding...
  18. ncbi request reprint The Preterm Prediction Study: association between maternal body mass index and spontaneous and indicated preterm birth
    Israel Hendler
    National Institute of Child Health and Human Development, Maternal Fetal Medicine Units Network, National Institutes of Health, Bethesda, MD, USA
    Am J Obstet Gynecol 192:882-6. 2005
    ..The purpose of this study was to evaluate the relationship between prepregnancy maternal body mass index and spontaneous preterm birth and indicated preterm birth...
  19. ncbi request reprint The Maternal-Fetal Medicine Units cesarean registry: chorioamnionitis at term and its duration-relationship to outcomes
    Dwight J Rouse
    Department of Obstetrics and Gynecology, Center for Research in Women s Health, University of Alabama at Birmingham, 35249 7333, USA
    Am J Obstet Gynecol 191:211-6. 2004
    ..The purpose of this study was to evaluate the relationship between chorioamnionitis and its duration to adverse maternal, fetal, and neonatal outcomes...
  20. ncbi request reprint Blood transfusion and cesarean delivery
    Dwight J Rouse
    Department of Obstetrics, The University of Alabama at Birmingham, Birmingham, Alabama 35249 7333, USA
    Obstet Gynecol 108:891-7. 2006
    ..To evaluate risks for intraoperative or postoperative packed red blood cell transfusion in women who underwent cesarean delivery...
  21. ncbi request reprint Are women with recurrent spontaneous preterm births different from those without such history?
    Brian M Mercer
    Department of Reproductive Biology, Case Western Reserve University, Cleveland, OH, USA
    Am J Obstet Gynecol 194:1176-84; discussion 1184-5. 2006
    ....
  22. ncbi request reprint The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth
    Atef H Moawad
    National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network, USA
    Am J Obstet Gynecol 186:990-6. 2002
    ..We investigated the relationship between 8 potential blood markers and subsequent spontaneous preterm birth in asymptomatic pregnant women...
  23. ncbi request reprint The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome
    Brian M Mercer
    NICHD MFMU Network, Bethesda, MD, USA
    Am J Obstet Gynecol 194:438-45. 2006
    ..The purpose of this study was to evaluate the associations between measured amniotic fluid volume and outcome after preterm premature rupture of membranes (PROM)...